Australia
BlueVoyant Unveils New Outcomes-Based Cyber Defense Platform: BlueVoyant Elements™
Elements converges internal and external cybersecurity capabilities, and
delivers unrivaled visibility, accuracy, and actionability via an end-to-end
offering
NEW YORK, June 7, 2022 /PRNewswire/ -- BlueVoyant
Telix to Present at Jefferies Healthcare Conference
MELBOURNE, Australia and INDIANAPOLIS, June 7, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR) advises t...
PHASE II STUDY OF PAXALISIB IN BRAIN METASTASES ADVANCES TO EXPANSION STAGE IN BREAST CANCER BRAIN METASTASES COHORT
SYDNEY, June 7, 2022 Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that a phase II, genomically-guided study of multiple therapies in patients with brain metastases, led by the Alliance for Clinical Trials in Oncology (NC...
China Matters Explores the birthplace of Cantonese Culture
BEIJING, June 7, 2022 /PRNewswire/ -- China is often talked about as having the biggest population in the world, with its economy as the headline grabber for most. But it's also a country that is geographically, and culturally diverse. It's almost like living in different spheres. There is an exc...
Landis+Gyr's EV Charging Business Picks Up Speed with Software Contract in New Zealand
Meridian Energy will deploy the OCEAN Charge Point Management System for the management and monetization of their public charging network across the country. CHAM, Switzerland, June 7, 2022 /PRNewswire/ -- Etrel, a Landis+Gyr (SIX: LAND) company providing integrated e-mobility solutions, and Meri...
Landis+Gyr's EV Charging Business Picks Up Speed with Software Contract in New Zealand
Meridian Energy will deploy the OCEAN Charge Point Management System for the management and monetization of their public charging network across the country. CHAM, Switzerland, June 7, 2022 /PRNewswire/ -- Etrel, a Landis+Gyr (SIX: LAND) company providing integrated e-mobility solutions, and Meri...
CapitaLand Investment acquires 22-storey office tower in Melbourne's CBD
Acquisition marks CLI's fifth investment in Australia within six months SINGAPORE, June 7, 2022 /PRNewswire/ -- CapitaLand Investment Limited (CLI) has acquired a freehold office tower in the Western Core of Melbourne's Central Business District for its flagship regional core-plus fund, Capit...
P.I. Works and VMware To Bolster O-RAN Adoption and Innovation
P.I. Works' rApps to be interoperable with VMware's Non-Real-Time RIC Platform to enable the automation and optimization of Open RAN networks RESTON, VA, June 7, 2022 /PRNewswire/ -- P.I. Works, the leading provider of AI-driven mobile network management solutions, has announced its rApps are...
Werkflo Releases the new FlowBiz™ suite
Chart. Allocate. Automate. SYDNEY, June 7, 2022 /PRNewswire/ -- Werkflo is pleased to release the newly upgraded FlowBiz™ suite to customers. FlowBiz™ is a cloud-based charting, integration and automation workflow solution that is unlike anything else on the market. "Within our unified platfo...
Telix Showcasing Innovation in Theranostics at SNMMI
MELBOURNE, Australia and INDIANAPOLIS, June 7, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its presence at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting to be held inVancouver from June 11-14. Gallium-based pr...
500 Financial Institutions now Live on the Taskize Network
LONDON, June 6, 2022 /PRNewswire/ -- Taskize
IND approval from the US FDA for Phase II SAR-Bombesin imaging trial in prostate cancer
Highlights * IND approval received for SAR-Bombesin product, enabling a Phase II "SABRE" imaging trial to detect prostate cancer in up to 50 PSMA-negative participants in the US * Approximately 20% of prostate cancer patients with biochemical recurrence (BCR) are PSMA-PET negative and theref...
Locus Unveils Order-to-Delivery Dispatch Management Platform to Transform Complex Last-Mile Logistics Operations
Debuted at Gartner Supply Chain Symposium, the new solution combines the power of advanced algorithms and intuitive automation to streamline logistics complexities, improve customer experience, and turn Last-Mile into a profitable business function SAN FRANCISCO and ORLANDO, Fla., June 6, 2022 /...
Medison Pharma Announces Multi-Regional Partnership Agreement with argenx to Commercialize Efgartigimod Across Europe and Israel
PETACH TIKVAH, Israel, June 6, 2022 /PRNewswire/ -- Medison Pharma
SocietyOne launches transaction & savings accounts powered by Westpac
SYDNEY, June 6, 2022 /PRNewswire/ -- In its first major corporate milestone
following its acquisition by MONEYME Ltd (ASX:MME), digital finance platform
SocietyOne has launched transaction and savings accounts powered by Westpac's
Banking-as-a-Service (BaaS).
Pepper Money's SOLANA Improves Business Volumes by 70% with the Appian Low-Code Platform
SYDNEY, June 6, 2022 /PRNewswire/ -- Appian (NASDAQ: APPN) announced today that Pepper Money, a leading consumer finance company inAustralia is using the Appian Low-Code Platform to support its Asset Finance Loan Origination solution, SOLANA, which has allowed the company to grow its business vol...
Gold Globee® Recognition Annature and founder CEO Amreeta Abbott at the Golden Bridge Awards
BRISBANE, Australia, June 6, 2022 /PRNewswire/ -- Annature CEO Amreeta Abbott
has continued her run of international award recognition by being named Woman
of the Year in Business and the Professions in the world's premier business
awards program, the Globee® Awards.
KAZIA PRESENTS POSITIVE FINAL DATA FROM PHASE II STUDY OF PAXALISIB IN NEWLY DIAGNOSED GLIOBLASTOMA AT ASCO CONFERENCE
SYDNEY, June 3, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce final data from its phase II study of paxalisib as first line therapy in patients with glioblastoma (NCT03522298). The data is the subj...
China Matters Featured the Impact of a 1,000-Year-Old Legacy in Today's China
BEIJING, June 2, 2022 /PRNewswire/ -- Who is Zhang Jiuling? Why does his 1,000-year-old legacy still matter today? Zhang Jiuling was a politician and writer who beat the odds with his integrity and hard work back in the Tang Dynasty (618-907). Zhang was a native of Shaoguan city in the historica...
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy
Multiple System Atrophy is a rare, rapidly progressive, neurodegenerative disease that causes profound disability MELBOURNE, Australia, June 2, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disea...
Week's Top Stories
Most Reposted
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 303 media titles]
2024-11-26 18:49ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 296 media titles]
2024-11-28 17:24Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 296 media titles]
2024-11-26 13:00MediSun Energy Raises $8.75M Seed Round with Vynn Capital to Drive MENA Expansion and Advance Osmotic Energy Innovation
[Picked up by 280 media titles]
2024-11-25 10:00Mentech at COP29: Showing the Eco-friendly Lifestyle with Technological Innovation
[Picked up by 275 media titles]
2024-11-29 20:33